ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,958Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 2061

$1.32M Total Retail Price of All Prescriptions

Rank: 48 out of 2061

808 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 808 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 808 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 22,141 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 1,437 1,112 1 2
SIMVASTATIN 1,166 993 2 1
OMEPRAZOLE 1,158 896 3 5
FUROSEMIDE 894 756 4 6
HYDROCHLOROTHIAZIDE 883 745 5 12
LEVOTHYROXINE SODIUM 876 710 6 3
METOPROLOL TARTRATE 570 510 7 7
HYDROCODONE-ACETAMINOPHEN 534 419 S3 8 10
AMLODIPINE BESYLATE 498 443 9 4
SERTRALINE HCL 456 412 10 21
METOPROLOL SUCCINATE 424 362 11 19
DONEPEZIL HCL 422 420 12 24
WARFARIN SODIUM 417 284 13 11
GABAPENTIN 397 258 14 15
METFORMIN HCL 390 305 15 9
POTASSIUM CHLORIDE 357 306 16 16
ATORVASTATIN CALCIUM 352 265 17 8
KLOR-CON M20 337 250 18 47
TRAMADOL HCL 329 244 19 18
CLOPIDOGREL 278 228 20 29
ATENOLOL 258 242 21 13
FAMOTIDINE 253 148 22 67
NEXIUM 249 187 23 26
LOSARTAN POTASSIUM 248 235 24 17
ALLOPURINOL 241 232 25 28
CITALOPRAM HBR 237 178 26 20
OXYCODONE-ACETAMINOPHEN 235 125 S2 27 36
NAMENDA 220 220 28 37
CARVEDILOL 213 149 29 22
GLIMEPIRIDE 213 186 29 33
ALENDRONATE SODIUM 212 190 31 25
TAMSULOSIN HCL 208 169 32 30
TRAZODONE HCL 199 153 33 39
CIPROFLOXACIN HCL 193 177 34 54
PLAVIX 191 157 35 49
CYMBALTA 191 117 35 59
ZOLPIDEM TARTRATE 189 133 37 23
MIRTAZAPINE 188 179 38 46
PAROXETINE HCL 187 154 39 61
QUETIAPINE FUMARATE 185 176 40 72
LANTUS 178 115 41 48
LEVOFLOXACIN 174 152 42 111
DIGOXIN 174 154 42 56
PRAVASTATIN SODIUM 173 141 44 14
AZITHROMYCIN 161 130 45 34
ISOSORBIDE MONONITRATE ER 141 95 46 42
PROAIR HFA 136 79 47 40
CARBIDOPA-LEVODOPA 134 134 48 97
LOVASTATIN 129 107 49 35
FENOFIBRATE 128 104 50 65
PREDNISONE 126 105 51 32
CYCLOBENZAPRINE HCL 125 59 R 52 78
GLIPIZIDE 123 88 53 55
FENTANYL 122 96 S2 54 84
SEROQUEL 122 92 54 157
DILTIAZEM 24HR CD 119 102 56 118
TRICOR 119 49 56 128
JANUVIA 119 108 56 51
OXYBUTYNIN CHLORIDE ER 117 80 59 80
ADVAIR DISKUS 117 88 59 57
MELOXICAM 116 84 61 44
SPIRIVA 115 60 62 63
CEPHALEXIN 113 100 63 112
TRIAMTERENE-HCTZ 112 110 64 38
LACTULOSE 108 37 65 131
SPIRONOLACTONE 105 57 66 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 99 67 87
FLUOXETINE HCL 100 61 68 73
AMOXICILLIN 99 80 69 121
FLOVENT HFA 98 48 70 280
CLOTRIMAZOLE-BETAMETHASONE 97 81 71 173
POLYETHYLENE GLYCOL 3350 96 79 72 64
CLONIDINE HCL 94 80 73 52
RISPERIDONE 93 73 74 66
VITAMIN D2 92 80 75 146
PHENYTOIN SODIUM EXTENDED 90 69 76 145
NOVOLOG 90 66 76 102
DIVALPROEX SODIUM 89 66 78 74
NYSTOP 89 73 78 185
ALBUTEROL SULFATE 88 74 80 104
RANITIDINE HCL 87 79 81 53
VENLAFAXINE HCL ER 83 72 82 109
OLANZAPINE 82 70 83 132
ALPRAZOLAM 79 57 84 85
ROPINIROLE HCL 74 64 85 92
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 65 85 27
PANTOPRAZOLE SODIUM 72 62 87 45
OXYCODONE HCL 72 17 S2 87 82
HYDRALAZINE HCL 71 26 89 69
DIVALPROEX SODIUM ER 70 22 90 188
FLUTICASONE PROPIONATE 70 45 90 43
DOXAZOSIN MESYLATE 69 58 92 81
ESCITALOPRAM OXALATE 66 54 93 77
CILOSTAZOL 66 33 93 189
DOXYCYCLINE HYCLATE 66 49 93 98
NITROFURANTOIN 65 65 96 206
PRAMIPEXOLE DIHYDROCHLORIDE 65 43 96 249
PROPRANOLOL HCL 62 37 98 143
KLOR-CON M10 62 55 98 125
IPRATROPIUM-ALBUTEROL 62 59 98 117
JANTOVEN 61 57 101 93
NOVOLIN R 60 46 102 129
NITROFURANTOIN MONO-MACRO 59 54 103 162
LYRICA 58 40 104 83
FINASTERIDE 58 46 104 86
AMOX TR-POTASSIUM CLAVULANATE 57 49 106 113
EXELON 56 56 107 94
NOVOLIN 70-30 55 48 108 213
CRESTOR 53 52 109 31
SINGULAIR 53 38 109 88
PRIMIDONE 51 42 111 255
SODIUM CHLORIDE 51 50 111 192
DIOVAN 51 46 111 41
HUMALOG 51 23 111 163
ENALAPRIL MALEATE 50 46 115 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.